{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T09:30:46Z","timestamp":1790501446951,"version":"4.1.0"},"reference-count":50,"publisher":"American Society of Hematology","issue":"13","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2018,7,10]]},"abstract":"<jats:title>Key Points<\/jats:title>\n               <jats:p>VWF variants c.2365A&gt;G and c.2385T&gt;C independently influence VWF biosynthesis and clearance, increasing VWF plasma levels. Commonly inherited VWF variants can directly influence the protein and may contribute to hemostatic and thrombotic disease risk\/severity.<\/jats:p>","DOI":"10.1182\/bloodadvances.2017011643","type":"journal-article","created":{"date-parts":[[2018,7,6]],"date-time":"2018-07-06T11:55:22Z","timestamp":1530878122000},"page":"1585-1594","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":18,"title":["The common VWF single nucleotide variants c.2365A&gt;G and c.2385T&gt;C modify VWF biosynthesis and clearance"],"prefix":"10.1182","volume":"2","author":[{"given":"Ahmad H.","family":"Mufti","sequence":"first","affiliation":[{"name":"Haemostasis Research Group, Department of Infection, Immunity & Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichi","family":"Ogiwara","sequence":"additional","affiliation":[{"name":"Richardson Laboratory, Department of Pathology and Molecular Medicine, Queen\u2019s University, Kingston, ON, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9620-8401","authenticated-orcid":false,"given":"Laura L.","family":"Swystun","sequence":"additional","affiliation":[{"name":"Richardson Laboratory, Department of Pathology and Molecular Medicine, Queen\u2019s University, Kingston, ON, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3268-5759","authenticated-orcid":false,"given":"Jeroen C. J.","family":"Eikenboom","sequence":"additional","affiliation":[{"name":"Einthoven Laboratory for Vascular and Regenerative Medicine, Department of Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, The Netherlands;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Budde","sequence":"additional","affiliation":[{"name":"H\u00e4mostaseology, Medilys Laborgesellschaft mbH, Hamburg, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilma M.","family":"Hopman","sequence":"additional","affiliation":[{"name":"Department of Public Health Sciences, Queen\u2019s University, Kingston, ON, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9355-3901","authenticated-orcid":false,"given":"Christer","family":"Halld\u00e9n","sequence":"additional","affiliation":[{"name":"Biomedicine, Kristianstad University, Kristianstad, Sweden; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny","family":"Goudemand","sequence":"additional","affiliation":[{"name":"Centre de R\u00e9f\u00e9rence Maladie de Willebrand, H\u00e9matologie, H\u00f4pital Cardiologique, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian R.","family":"Peake","sequence":"additional","affiliation":[{"name":"Haemostasis Research Group, Department of Infection, Immunity & Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6177-7062","authenticated-orcid":false,"given":"Anne C.","family":"Goodeve","sequence":"additional","affiliation":[{"name":"Haemostasis Research Group, Department of Infection, Immunity & Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Lillicrap","sequence":"additional","affiliation":[{"name":"Richardson Laboratory, Department of Pathology and Molecular Medicine, Queen\u2019s University, Kingston, ON, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1387-8926","authenticated-orcid":false,"given":"Daniel J.","family":"Hampshire","sequence":"additional","affiliation":[{"name":"Haemostasis Research Group, Department of Infection, Immunity & Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2018,7,6]]},"reference":[{"issue":"1","key":"2019111618034814300_B1","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1146\/annurev.biochem.67.1.395","article-title":"Biochemistry and genetics of von Willebrand factor","volume":"67","author":"Sadler","year":"1998","journal-title":"Annu Rev Biochem"},{"issue":"6","key":"2019111618034814300_B2","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1182\/blood-2002-09-2892","article-title":"von Willebrand disease type 1: a diagnosis in search of a disease","volume":"101","author":"Sadler","year":"2003","journal-title":"Blood"},{"issue":"13","key":"2019111618034814300_B3","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1161\/01.CIR.101.13.1546","article-title":"Genetic determinants of hemostasis phenotypes in Spanish families","volume":"101","author":"Souto","year":"2000","journal-title":"Circulation"},{"issue":"3","key":"2019111618034814300_B4","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1160\/TH05-09-0596","article-title":"Genetic influences on fibrinogen, tissue plasminogen activator-antigen and von Willebrand factor in males and females","volume":"95","author":"de Lange","year":"2006","journal-title":"Thromb Haemost"},{"issue":"6","key":"2019111618034814300_B5","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1182\/blood.V69.6.1691.1691","article-title":"The effect of ABO blood group on the diagnosis of von Willebrand disease","volume":"69","author":"Gill","year":"1987","journal-title":"Blood"},{"issue":"4","key":"2019111618034814300_B6","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1182\/blood.V73.4.990.990","article-title":"Possible effect of secretor locus on plasma concentration of factor VIII and von Willebrand factor","volume":"73","author":"\u00d8rstavik","year":"1989","journal-title":"Blood"},{"issue":"12","key":"2019111618034814300_B7","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1161\/CIRCULATIONAHA.109.869156","article-title":"Novel associations of multiple genetic loci with plasma levels of factor VII, factor VIII, and von Willebrand factor: The CHARGE (Cohorts for Heart and Aging Research in Genome Epidemiology) Consortium","volume":"121","author":"Smith","year":"2010","journal-title":"Circulation"},{"issue":"4","key":"2019111618034814300_B8","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1182\/blood-2013-02-485094","article-title":"Common and rare von Willebrand factor (VWF) coding variants, VWF levels, and factor VIII levels in African Americans: the NHLBI Exome Sequencing Project","volume":"122","author":"Johnsen","year":"2013","journal-title":"Blood"},{"issue":"4","key":"2019111618034814300_B9","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1046\/j.1523-1755.2000.00988.x","article-title":"Association between high von Willebrand factor levels and the Thr789Ala vWF gene polymorphism but not with nephropathy in type I diabetes","volume":"57","author":"Lacquemant","year":"2000","journal-title":"Kidney Int"},{"issue":"1","key":"2019111618034814300_B10","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/1471-2350-12-102","article-title":"Combined analysis of three genome-wide association studies on vWF and FVIII plasma levels","volume":"12","author":"Antoni","year":"2011","journal-title":"BMC Med Genet"},{"issue":"7","key":"2019111618034814300_B11","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1111\/j.1538-7836.2012.04771.x","article-title":"von Willebrand factor plasma levels, genetic variations and coronary heart disease in an older population","volume":"10","author":"van Loon","year":"2012","journal-title":"J Thromb Haemost"},{"issue":"4","key":"2019111618034814300_B12","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1182\/blood-2010-03-273961","article-title":"Variation in the von Willebrand factor gene is associated with von Willebrand factor levels and with the risk for cardiovascular disease","volume":"117","author":"van Schie","year":"2011","journal-title":"Blood"},{"issue":"19","key":"2019111618034814300_B13","doi-asserted-by":"crossref","first-page":"5224","DOI":"10.1182\/blood-2010-08-300152","article-title":"Genetic determinants of plasma von Willebrand factor antigen levels: a target gene SNP and haplotype analysis of ARIC cohort","volume":"117","author":"Campos","year":"2011","journal-title":"Blood"},{"issue":"4","key":"2019111618034814300_B14","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/j.1538-7836.2012.04634.x","article-title":"Genetic determinants of von Willebrand factor plasma levels and the risk of stroke: the Rotterdam Study","volume":"10","author":"van Schie","year":"2012","journal-title":"J Thromb Haemost"},{"issue":"1","key":"2019111618034814300_B15","doi-asserted-by":"crossref","first-page":"e84810","DOI":"10.1371\/journal.pone.0084810","article-title":"Possible race and gender divergence in association of genetic variations with plasma von Willebrand factor: a study of ARIC and 1000 genome cohorts","volume":"9","author":"Zhou","year":"2014","journal-title":"PLoS One"},{"issue":"4","key":"2019111618034814300_B16","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/j.1469-1809.2011.00654.x","article-title":"Genetic variants associated with von Willebrand factor levels in healthy men and women identified using the HumanCVD BeadChip","volume":"75","author":"Zabaneh","year":"2011","journal-title":"Ann Hum Genet"},{"issue":"7571","key":"2019111618034814300_B17","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/nature15393","article-title":"A global reference for human genetic variation","volume":"526","author":"1000 Genomes Project Consortium","year":"2015","journal-title":"Nature"},{"issue":"7616","key":"2019111618034814300_B18","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/nature19057","article-title":"Analysis of protein-coding genetic variation in 60,706 humans","volume":"536","author":"Lek","year":"2016","journal-title":"Nature"},{"issue":"8","key":"2019111618034814300_B19","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1182\/blood-2011-10-383661","article-title":"Influence of single nucleotide polymorphisms in factor VIII and von Willebrand factor genes on plasma factor VIII activity: the ARIC Study","volume":"119","author":"Campos","year":"2012","journal-title":"Blood"},{"issue":"3","key":"2019111618034814300_B20","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1046\/j.1365-2141.2002.03488.x","article-title":"Large experience with a factor VIII binding assay of plasma von Willebrand factor using commercial reagents","volume":"117","author":"Caron","year":"2002","journal-title":"Br J Haematol"},{"issue":"1","key":"2019111618034814300_B21","first-page":"77","article-title":"A sensitive ristocetin co-factor activity assay with recombinant glycoprotein Ibalpha for the diagnosis of patients with low von Willebrand factor levels","volume":"89","author":"Federici","year":"2004","journal-title":"Haematologica"},{"issue":"4","key":"2019111618034814300_B22","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1111\/j.1538-7836.2006.01847.x","article-title":"A quantitative analysis of bleeding symptoms in type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1 VWD)","volume":"4","author":"Tosetto","year":"2006","journal-title":"J Thromb Haemost"},{"issue":"4","key":"2019111618034814300_B23","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1111\/j.1538-7836.2006.01823.x","article-title":"Linkage analysis in families diagnosed with type 1 von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 VWD","volume":"4","author":"Eikenboom","year":"2006","journal-title":"J Thromb Haemost"},{"issue":"12","key":"2019111618034814300_B24","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1182\/blood-2012-09-455089","article-title":"VWF propeptide and ratios between VWF, VWF propeptide, and FVIII in the characterization of type 1 von Willebrand disease","volume":"121","author":"Eikenboom","year":"2013","journal-title":"Blood"},{"issue":"4","key":"2019111618034814300_B25","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/j.1469-1809.2011.00652.x","article-title":"Variation in the VWF gene in Swedish patients with type 1 von Willebrand Disease","volume":"75","author":"Johansson","year":"2011","journal-title":"Ann Hum Genet"},{"issue":"7","key":"2019111618034814300_B26","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1182\/blood.V97.7.2059","article-title":"Expression and characterization of von Willebrand factor dimerization defects in different types of von Willebrand disease","volume":"97","author":"Schneppenheim","year":"2001","journal-title":"Blood"},{"issue":"23","key":"2019111618034814300_B27","doi-asserted-by":"crossref","first-page":"4862","DOI":"10.1182\/blood-2009-11-253120","article-title":"Mutation-specific hemostatic variability in mice expressing common type 2B von Willebrand disease substitutions","volume":"115","author":"Golder","year":"2010","journal-title":"Blood"},{"issue":"4","key":"2019111618034814300_B28","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-\u0394 \u0394 C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"issue":"1","key":"2019111618034814300_B29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1475-2867-2-1","article-title":"Real-time RT-PCR analysis of mRNA decay: half-life of beta-actin mRNA in human leukemia CCRF-CEM and Nalm-6 cell lines","volume":"2","author":"Leclerc","year":"2002","journal-title":"Cancer Cell Int"},{"issue":"16","key":"2019111618034814300_B30","doi-asserted-by":"crossref","first-page":"4358","DOI":"10.1182\/blood-2010-08-303727","article-title":"Pathologic mechanisms of type 1 VWD mutations R1205H and Y1584C through in vitro and in vivo mouse models","volume":"117","author":"Pruss","year":"2011","journal-title":"Blood"},{"issue":"3","key":"2019111618034814300_B31","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1182\/blood-2013-11-540534","article-title":"A von Willebrand factor fragment containing the D\u2019D3 domains is sufficient to stabilize coagulation factor VIII in mice","volume":"124","author":"Yee","year":"2014","journal-title":"Blood"},{"issue":"8","key":"2019111618034814300_B32","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1111\/jth.13749","article-title":"Abnormal von Willebrand factor secretion, factor VIII stabilization and thrombus dynamics in type 2N von Willebrand disease mice","volume":"15","author":"Swystun","year":"2017","journal-title":"J Thromb Haemost"},{"issue":"5","key":"2019111618034814300_B33","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1002\/art.24497","article-title":"Mann-Whitney U test and Kruskal-Wallis test should be used for comparisons of differences in medians, not means: comment on the article by van der Helm-van Mil et al","volume":"60","author":"Zhang","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"5","key":"2019111618034814300_B34","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1111\/jth.13294","article-title":"Aging and ABO blood type influence von Willebrand factor and factor VIII levels through interrelated mechanisms","volume":"14","author":"Alb\u00e1nez","year":"2016","journal-title":"J Thromb Haemost"},{"issue":"2","key":"2019111618034814300_B35","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/bioinformatics\/bth457","article-title":"Haploview: analysis and visualization of LD and haplotype maps","volume":"21","author":"Barrett","year":"2005","journal-title":"Bioinformatics"},{"issue":"2","key":"2019111618034814300_B36","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/nrm.2016.139","article-title":"The roles of RNA processing in translating genotype to phenotype","volume":"18","author":"Manning","year":"2017","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"6","key":"2019111618034814300_B37","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1111\/j.1365-2516.2010.02271.x","article-title":"A novel alanine or threonine 789 to proline mutation causing type 2N von Willebrand\u2019s disease when inherited homozygously or heterozygously with arginine 854 to glutamine mutation","volume":"16","author":"Enayat","year":"2010","journal-title":"Haemophilia"},{"issue":"1","key":"2019111618034814300_B38","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-2516.2009.02005.x","article-title":"Factor VIII and von Willebrand factor interaction: biological, clinical and therapeutic importance","volume":"16","author":"Terraube","year":"2010","journal-title":"Haemophilia"},{"issue":"8","key":"2019111618034814300_B39","doi-asserted-by":"crossref","first-page":"e0132626","DOI":"10.1371\/journal.pone.0132626","article-title":"Quantitative influence of ABO blood groups on factor VIII and its ratio to von Willebrand factor, novel observations from an ARIC study of 11,673 subjects","volume":"10","author":"Song","year":"2015","journal-title":"PLoS One"},{"issue":"13","key":"2019111618034814300_B40","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1182\/blood-2014-06-528406","article-title":"von Willebrand factor biosynthesis, secretion, and clearance: connecting the far ends","volume":"125","author":"Lenting","year":"2015","journal-title":"Blood"},{"issue":"4","key":"2019111618034814300_B41","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/jth.12160","article-title":"Weibel-Palade bodies: a window to von Willebrand disease","volume":"11","author":"Valentijn","year":"2013","journal-title":"J Thromb Haemost"},{"issue":"1","key":"2019111618034814300_B42","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1038\/srep01318","article-title":"Genome-wide survey of interindividual differences of RNA stability in human lymphoblastoid cell lines","volume":"3","author":"Duan","year":"2013","journal-title":"Sci Rep"},{"issue":"9","key":"2019111618034814300_B43","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1111\/jth.13401","article-title":"Genome-wide studies of von Willebrand factor propeptide identify loci contributing to variation in propeptide levels and von Willebrand factor clearance","volume":"14","author":"Ozel","year":"2016","journal-title":"J Thromb Haemost"},{"issue":"3","key":"2019111618034814300_B44","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.blre.2010.03.003","article-title":"The genetic basis of von Willebrand disease","volume":"24","author":"Goodeve","year":"2010","journal-title":"Blood Rev"},{"issue":"1","key":"2019111618034814300_B45","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1365-2141.2009.08074.x","article-title":"Venous thrombosis of the upper extremity: effect of blood group and coagulation factor levels on risk","volume":"149","author":"Flinterman","year":"2010","journal-title":"Br J Haematol"},{"issue":"2","key":"2019111618034814300_B46","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1538-7836.2010.04134.x","article-title":"Plasma levels of von Willebrand factor in the etiologic subtypes of ischemic stroke","volume":"9","author":"Hanson","year":"2011","journal-title":"J Thromb Haemost"},{"issue":"1","key":"2019111618034814300_B47","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1177\/2048872614534388","article-title":"Plasma levels of active von Willebrand factor are increased in patients with first ST-segment elevation myocardial infarction: a multicenter and multiethnic study","volume":"4","author":"Rutten","year":"2015","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"issue":"22","key":"2019111618034814300_B48","doi-asserted-by":"crossref","first-page":"6007","DOI":"10.1182\/blood-2010-10-315473","article-title":"Genetic variation associated with plasma von Willebrand factor levels and the risk of incident venous thrombosis","volume":"117","author":"Smith","year":"2011","journal-title":"Blood"},{"issue":"10","key":"2019111618034814300_B49","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1111\/j.1538-7836.2011.04443.x","article-title":"Racial differences in venous thromboembolism","volume":"9","author":"Zakai","year":"2011","journal-title":"J Thromb Haemost"},{"issue":"9","key":"2019111618034814300_B50","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1182\/blood-2006-04-014688","article-title":"Enhanced VWF biosynthesis and elevated plasma VWF due to a natural variant in the murine Vwf gene","volume":"108","author":"Lemmerhirt","year":"2006","journal-title":"Blood"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/2\/13\/1585\/881342\/advances011643.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/2\/13\/1585\/881342\/advances011643.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,16]],"date-time":"2019-11-16T18:04:30Z","timestamp":1573927470000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/2\/13\/1585\/15932\/The-common-VWF-single-nucleotide-variants"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,6]]},"references-count":50,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2018,7,10]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2017011643","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,6]]}}}